Archive for December 2022
Andarix Pharmaceuticals to Present at Clinical Trials in Rare Diseases Conference 2022
Personalized and targeted medicine for rare lung and other cancers SOMERVILLE, MA —December 6, 2022— ANDARIX Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for cancer announced today that it will present its clinical strategy and results at the upcoming clinical trials in rare diseases conference. The Clinical Trials in Rare…
Read More